{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:12:43Z","timestamp":1793891563575,"version":"4.8.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.resinv.2023.04.010","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T11:52:15Z","timestamp":1688385135000},"page":"563-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Current status and future landscape of diagnosing tuberculosis infection"],"prefix":"10.1016","volume":"61","author":[{"given":"Yoshihiro","family":"Kobashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2023.04.010_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-2600(19)30418-7","article-title":"WHO global progress report on tuberculosis elimination","volume":"8","author":"Harding","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2023.04.010_bib2","series-title":"Guidelines on the management of latent tuberculosis infection","year":"2015"},{"key":"10.1016\/j.resinv.2023.04.010_bib3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2023.04.010_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.resinv.2023.04.010_bib5","series-title":"QuantiFERON-TB gold plus ELISA package insert","year":"2014"},{"issue":"Suppl 1","key":"10.1016\/j.resinv.2023.04.010_bib6","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ijmyco.2016.09.063","article-title":"Characterization of the CD4 and CD8 T-cell response in the qunatifgeron-tb gold plus kit","volume":"5","author":"Petruccioli","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.resinv.2023.04.010_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12995-016-0148-z","article-title":"QFT-Plus: a plus in variability? - evaluation of new generation IGRA in serial testing of students with a migration background in Germany","volume":"12","author":"Knierer","year":"2017","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.resinv.2023.04.010_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jinf.2014.06.009","article-title":"Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients","volume":"69","author":"Chiacchio","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201107-1355OC","article-title":"Tuberculosis Research Unit. CD8+ T cells provide an immunologic signature of tuberculosis in young children","volume":"185","author":"Lancioni","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2023.04.010_bib10","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/eji.201243262","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease","volume":"43","author":"Rozot","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.resinv.2023.04.010_bib11","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1093\/cid\/ciaa1822","article-title":"Comparing the diagnostic performance of QuantiFERON-TB Gold plus to other tests of latent tuberculosis infection: a systematic review and meta-analysis","volume":"73","author":"Oh","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jinf.2019.08.018","article-title":"QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"79","author":"Sotgiu","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.advms.2019.09.001","article-title":"Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-\u03b3 release assays: a systematic review and meta-analysis","volume":"64","author":"Pourakbari","year":"2019","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.resinv.2023.04.010_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01950-19","article-title":"Fourth-generation QuantiFERON-TB gold plus: what is the evidence?","volume":"58","author":"Shafeque","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2023.04.010_bib15","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/spectrum.01870-21","article-title":"Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the diagnosis of Mycobacterium tuberculosis infections in immunocompromised patients: a real-world study","volume":"10","author":"Xu","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.resinv.2023.04.010_bib16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jinf.2020.02.009","article-title":"Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection","volume":"80","author":"Petruccioli","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jiac.2019.02.018","article-title":"Positivity rate of interferon-\u03b3 release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan","volume":"25","author":"Igari","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2023.04.010_bib18","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.jiac.2021.08.016","article-title":"Clinical evaluation of QuantiFERON-TB Gold Plus directly compared with QuantiFERON-TB Gold In-Tube and T-Spot.TB for active pulmonary tuberculosis in the elderly","volume":"27","author":"Fukushima","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2023.04.010_bib19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4269\/ajtmh.18-0674","article-title":"Evaluation of the QuantiFERON-TB Gold Plus assay in children with tuberculosis disease or following household exposure to tuberculosis","volume":"100","author":"Kay","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.resinv.2023.04.010_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/JCM.00272-20","article-title":"Accuracy of QuantiFERON-TB Gold Plus test for diagnosis of Mycobacterium tuberculosis infection in children","volume":"58","author":"Buonsenso","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2023.04.010_bib21","first-page":"68","article-title":"Can interferon-\u03b3 release assays be useful for monitoring the response to anti-tuberculous treatment?: a systematic review and meta-analysis","volume":"4","author":"Pourakbari","year":"2020","journal-title":"Arch Immunol Ther Exp"},{"key":"10.1016\/j.resinv.2023.04.010_bib22","first-page":"1242","article-title":"Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test","volume":"9","author":"Zellweger","year":"2005","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib23","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/thoraxjnl-2018-211715","article-title":"Evaluating latent tuberculosis infection diagnostics using latent class analysis","volume":"83","author":"Stout","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2023.04.010_bib24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1186\/s12879-019-4597-8","article-title":"Clinical effect of T-SPOT.TB test for the diagnosis of tuberculosis","volume":"19","author":"Ma","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1756-185X.12772","article-title":"Evaluation of interferon-gamma release assay (T-SPOT.TB) for diagnosis of tuberculosis infection in rheumatic disease patients","volume":"19","author":"Jiang","year":"2016","journal-title":"Intern J Rheumatic Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2023.04.010_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","article-title":"Interferon-\u03b3-release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis","volume":"37","author":"Sester","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.04.010_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jiac.2020.06.019","article-title":"Comparison of QuantiFERON-TB gold plus, QuantiFERON-TB gold in-tube, and T-SPOT.TB among patients with tuberculosis","volume":"26","author":"Takeda","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2023.04.010_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lfs.2018.02.004","article-title":"Evaluation of interferon-gamma release assays in extrasanguinous body fluids for diagnosing tuberculosis: a systematic review and meta-analysis","volume":"197","author":"Wen","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.resinv.2023.04.010_bib30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1186\/s12879-020-05578-3","article-title":"Performance of Xpert MTB\/RIF in diagnosing tuberculous pleuritis using thoracoscopic pleural biopsy","volume":"20","author":"Li","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102223","article-title":"The diagnostic value of T cell spot test and adenosine deaminase in pleural effusion for tuberculous pleurisy: a systematic review and meta-analysis","volume":"135","author":"Zhang","year":"2022","journal-title":"Tuberculosis"},{"key":"10.1016\/j.resinv.2023.04.010_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.101941","article-title":"Diagnostic value of pleural fluid T-SPOT for tuberculous pleurisy: an updated meta-analysis","volume":"122","author":"Luo","year":"2020","journal-title":"Tuberculosis"},{"key":"10.1016\/j.resinv.2023.04.010_bib33","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1128\/JCM.00823-15","article-title":"Interferon gamma release assays for diagnosis of pleural tuberculosis: a systematic review and meta-analysis","volume":"53","author":"Aggarwal","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2023.04.010_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.585180","article-title":"Diagnostic value of T-SPOT.TB assay for tuberculous peritonitis: a meta-analysis","volume":"7","author":"Luo","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.resinv.2023.04.010_bib35","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3389\/fneur.2020.00866","article-title":"Diagnostic accuracy of T-SPOT.TB assay for tuberculous meningitis: an updated meta-analysis","volume":"11","author":"Luo","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.resinv.2023.04.010_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.788692","article-title":"Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a systematic review and meta-analysis","volume":"12","author":"Wen","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.resinv.2023.04.010_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02189-2017","article-title":"Rapid diagnosis of tuberculosis combined molecular and immunological methods","volume":"51","author":"Jafari","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.04.010_bib38","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.5588\/ijtld.13.0108","article-title":"Comparison of molecular and immunological methods for the rapid diagnosis of smear-negative tuberculosis","volume":"17","author":"Jafari","year":"2013","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF00184787","article-title":"Distribution of lymphocyte subsets and natural killer cells in the human body","volume":"70","author":"Westermann","year":"1992","journal-title":"Clin Invest"},{"key":"10.1016\/j.resinv.2023.04.010_bib40","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1128\/JB.00683-09","article-title":"Region of difference 1 in nontuberculous mycobacterium species adds a phylogenetic and taxonomical character","volume":"191","author":"van Ingen","year":"2009","journal-title":"J Bacteriol"},{"key":"10.1016\/j.resinv.2023.04.010_bib41","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between mycobacterium bovis BCG and virulent M. bovis","volume":"176","author":"Mahairas","year":"1996","journal-title":"J Bacteriol"},{"key":"10.1016\/j.resinv.2023.04.010_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/iai.64.1.16-22.1996","article-title":"Evidence of occurrence of the ESAT-6 protein in mycobacterium tuberculosis and virulent mycobacterium bovis and for its absence in mycobacterium bovis BCG","volume":"64","author":"Harbor","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.resinv.2023.04.010_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21307\/pjm-2019-002","article-title":"Interferon gamma release assays in patients with respiratory isolates of non-tuberculous mycobacteria- preliminary study","volume":"68","author":"Kopec","year":"2019","journal-title":"Pol J Microbiol"},{"key":"10.1016\/j.resinv.2023.04.010_bib44","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jinf.2016.03.011","article-title":"Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: a retrospective survey","volume":"72","author":"Sato","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib45","first-page":"1422","article-title":"Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease","volume":"13","author":"Kobashi","year":"2009","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093986","article-title":"Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark","volume":"9","author":"Hermansen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2023.04.010_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038556","article-title":"Factors associated with the performance of a blood-based interferon-gamma release assay in diagnosing tuberculosis","volume":"7","author":"Banfield","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2023.04.010_bib48","first-page":"1","article-title":"High proportion of indeterminate QuantiFERON-TB Gold In-Tube results in an inpatient population is related to host factors and preanalytical steps","volume":"19","author":"Fabre","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib49","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01267-2017","article-title":"Frequency and significance in indeterminate and borderline QuantiFERON Gold TB IGRA results","volume":"50","author":"Brown","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.04.010_bib50","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1038\/s41598-017-07785-6","article-title":"Analysis of factors influencing diagnostic accuracy of T-SPOT.TB for active tuberculosis in clinical practice","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2023.04.010_bib51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/ofid\/ofy184","article-title":"Risk factors for indeterminate outcome on interferon gamma\u00a0release assay in non-US-born persons screened for latent tuberculosis infection","volume":"5","author":"Sharninghausen","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib52","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1128\/Spectrum.00096-21","article-title":"Retrospective performance analysis of over two million US QuantiFERON blood sample results","volume":"9","author":"Bi","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.resinv.2023.04.010_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17534666221077817","article-title":"In-hospital blood collection increases the rate of indeterminate results in interferon-gamma release assays","volume":"16","author":"Osakabe","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib54","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pulmoe.2019.11.001","article-title":"Host factors associated to false negative and indeterminate results in an interferon-\u03b3 release assay in patients with active tuberculosis","volume":"26","author":"Santos","year":"2020","journal-title":"Pulmonology"},{"key":"10.1016\/j.resinv.2023.04.010_bib55","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3855\/jidc.12063","article-title":"Risk factors for negative T-SPOT.TB assay results in patients with confirmed active tuberculosis. A retrospective -study","volume":"14","author":"Shangguan","year":"2020","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.resinv.2023.04.010_bib56","article-title":"Significant difference in Th1\/Th2 paradigm induced by tuberculosis-specific antigens between IGRA-positive and IGRA-negative patients","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2023.04.010_bib57","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02665-2021","article-title":"Biomarkers to identify Mycobacterium tuberculosis infection among borderline QuantiFERON results","volume":"60","author":"Uzorka","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.04.010_bib58","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tube.2007.11.009","article-title":"Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis","volume":"88","author":"Higuchi","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1016\/j.resinv.2023.04.010_bib59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00408-010-9238-3","article-title":"Comparison of T-cell interferon-\u03b3 release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis","volume":"188","author":"Kobashi","year":"2010","journal-title":"Lung"},{"key":"10.1016\/j.resinv.2023.04.010_bib60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jinf.2014.12.011","article-title":"Discrimination between latent and active tuberculosis: the role of interleukin-2 as biomarker","volume":"70","author":"Mamishi","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib61","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s10096-014-2190-z","article-title":"Diagnostic accuracy of IL2 for the diagnosis of latent tuberculosis: a systematic review and meta-analysis","volume":"33","author":"Mamishi","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib62","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jiac.2020.11.023","article-title":"IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection","volume":"27","author":"Akashi","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2023.04.010_bib63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00005-020-00568-4","article-title":"Can interferon-\u03b3 release assays be useful for monitoring the response to anti-tuberculous treatment?: a systematic review and meta-analysis","volume":"68","author":"Pourakbari","year":"2020","journal-title":"Arch Immunol Ther Exp"},{"key":"10.1016\/j.resinv.2023.04.010_bib64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jinf.2017.04.011","article-title":"Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis","volume":"75","author":"Clifford","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib65","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and interpretation of serial QuantiFERON testing to measure acquisition of Mycobacterium tuberculosis infection","volume":"196","author":"Nemes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2023.04.010_bib66","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1513\/AnnalsATS.201310-378OC","article-title":"IFN-\u03b3 release assay conversions and reversions. Challenges with serial testing in US health care workers","volume":"11","author":"Joshi","year":"2014","journal-title":"Annals ATS"},{"key":"10.1016\/j.resinv.2023.04.010_bib67","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jinf.2019.01.008","article-title":"Serial testing of Mycobacterium tuberculosis infection in Chinese village doctors by QuantiFERON-TB gold plus, QuantiFERON-TB gold in-tube and T-SPOT.TB","volume":"78","author":"Zhang","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1745-6673-7-6","article-title":"Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review","volume":"7","author":"Ringshausen","year":"2012","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.resinv.2023.04.010_bib69","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tube.2018.06.002","article-title":"Borderline QuantiFERON results and the distinction between specific responses and test variability","volume":"111","author":"Uzorka","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.resinv.2023.04.010_bib70","first-page":"A4101","article-title":"Diagnosis of latent tuberculosis infection in US health care workers: reproducibility, repeatability and 6 months follow-up with interferon-gamma assays (IGRAs)","volume":"179","author":"Belknap","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2023.04.010_bib71","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/CVI.05058-11","article-title":"Within-subject variability of mycobacterium tuberculosis-specific gamma interferon responses in German health care workers","volume":"18","author":"Ringhausen","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.resinv.2023.04.010_bib72","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00167-2021","article-title":"Tests for tuberculous infection: landscape analysis","volume":"58","author":"Hamada","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.04.010_bib73","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/jcm.00551-22","article-title":"Novel automation of an enzyme-linked immunosorbent spot assay testing method: comparable diagnostic performance of the T-SPOT.TB test using manual density gradient cell isolation versus automated positive selection with the T-cell select kit","volume":"60","author":"Wang","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2023.04.010_bib74","doi-asserted-by":"crossref","first-page":"e1347","DOI":"10.1128\/JCM.01347-19","article-title":"Evaluation of standard E-TB-Feron Enzyme-linked immunosorbent assay for diagnosis of latent tuberculosis infection in health care workers","volume":"57","author":"Kweon","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2023.04.010_bib75","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/diagnostics11091659","article-title":"Comparative evaluation of standard E TB-Feron ELISA and QuantiFERON-TB Gold Plus assays in patients with tuberculosis and healthcare workers","volume":"11","author":"Yoo","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.resinv.2023.04.010_bib76","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijid.2019.12.012","article-title":"LIOFeron TB\/LTBI: a novel and reliable test for LTBI and tuberculosis","volume":"91","author":"Bella","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib77","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1128\/JCM.00159-20","article-title":"Evaluation of QuantiFERON-TB gold plus on Liaison XL in a low-tuberculosis-incidence setting","volume":"58","author":"Maertelaere","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2023.04.010_bib78","first-page":"1287","article-title":"Performance of an advanced interferon-gamma release assay for Mycobacterium tuberculosis detection","volume":"6","author":"Altawallbeh","year":"2021","journal-title":"JALM"},{"key":"10.1016\/j.resinv.2023.04.010_bib79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3343\/alm.2020.40.1.33","article-title":"Performance evaluation of a new automated chemiluminescent immunoanalyser-based interferon-gamma releasing assay AdvanSure 13 in comparison with the QuantiFERON-TB Gold In-Tube assay","volume":"40","author":"Kim","year":"2020","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.resinv.2023.04.010_bib80","doi-asserted-by":"crossref","first-page":"917","DOI":"10.5588\/ijtld.21.0391","article-title":"Evaluation of a novel lateral flow nanoparticle fluorescence assay for TB infection diagnosis","volume":"25","author":"Stieber","year":"2021","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pulmoe.2021.07.003","article-title":"First clinical evaluation of the QIAreach QuantiFERON-TB for tuberculosis infection and active pulmonary disease","volume":"27","author":"Fukushima","year":"2022","journal-title":"Pulmonology"},{"key":"10.1016\/j.resinv.2023.04.010_bib82","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02563-2021","article-title":"QIAreach QuantiFERON-TB for the diagnosis of Mycobacterium tuberculosis infection","volume":"59","author":"Saluzzo","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.04.010_bib83","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3349\/ymj.2019.60.4.375","article-title":"A feasibility study for diagnosis of latent tuberculosis infection using an IGRA point-of-care platform in South Korea","volume":"60","author":"Hur","year":"2019","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.resinv.2023.04.010_bib84","series-title":"Reliable and fully automated solution for tuberculosis (TB) infection detection","year":"2020"},{"key":"10.1016\/j.resinv.2023.04.010_bib85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5588\/ijtld.21.0478","article-title":"VIDAS TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-\u03b3 response for both TB infection and active TB","volume":"26","author":"Putruccioli","year":"2021","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.resinv.2023.04.010_bib86","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-\u03b3 horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis","volume":"43","author":"Chegou","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.04.010_bib87","series-title":"Framework for evaluation of new tests for tuberculosis infection","first-page":"2021","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.resinv.2023.04.010_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254571","article-title":"Mycobacterial heparin-binding hemagglutinin (HABA)-induced interferon-\u03b3 release assay (IGRA) for discrimination of latent and active tuberculosis: a systematic review and meta-analysis","volume":"16","author":"Tang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2023.04.010_bib89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.00140009","article-title":"Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection","volume":"36","author":"Goletti","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.04.010_bib90","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3389\/fimmu.2018.02476","article-title":"A systematic review on novel mycobacterium tuberculosis antigens and their discriminatory potential for the diagnosis of latent and active tuberculosis","volume":"9","author":"Meier","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2023.04.010_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2022.105002","article-title":"Novel serological biomarker panel using protein microassay can distinguish active TB and latent TB infection","volume":"24","author":"Li","year":"2022","journal-title":"Microb Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib92","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1038\/s41598-018-20855-7","article-title":"Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis","volume":"8","author":"Chegou","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2023.04.010_bib93","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jinf.2019.07.007","volume":"79","author":"Manngo","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib94","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jinf.2020.02.007","article-title":"Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis","volume":"80","author":"Suzukawa","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib95","doi-asserted-by":"crossref","first-page":"532","DOI":"10.21037\/apm-21-3739","article-title":"Molecular markers of tuberculosis and their clinical relevance: a systematic review and meta-analysis","volume":"11","author":"Xu","year":"2022","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.resinv.2023.04.010_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102242","article-title":"Evaluation of tuberculosis diagnostic biomarkers in immunocompromised hosts based on cytokine levels in QuantiFERON-TB Gold Plus","volume":"136","author":"Imoto","year":"2022","journal-title":"Tuberculosis"},{"key":"10.1016\/j.resinv.2023.04.010_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152483","article-title":"Combined analysis of IFN-\u03b3 IL-2, IL-5, IL-10, IL-1RA, and MCP-1 in QFT supernatant is useful for distinguishing active tuberculosis from latent infection","volume":"11","author":"Suzukawa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2023.04.010_bib98","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tube.2016.06.001","article-title":"Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection","volume":"102","author":"Wu","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.resinv.2023.04.010_bib99","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2018.10.017","article-title":"Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection","volume":"78","author":"Luo","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jiac.2020.11.023","article-title":"IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection","volume":"27","author":"Akashi","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2023.04.010_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102256","article-title":"Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis","volume":"136","author":"Zhou","year":"2022","journal-title":"Tuberculosis"},{"key":"10.1016\/j.resinv.2023.04.010_bib102","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/07853890.2020.1800073","article-title":"Is interleukin-2 an optical marker for diagnosing tuberculosis infection? A systematic review and meta-analysis","volume":"52","author":"Qiu","year":"2020","journal-title":"Ann Med"},{"key":"10.1016\/j.resinv.2023.04.010_bib103","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jinf.2020.09.032","article-title":"Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: a systematic review","volume":"81","author":"Sudbury","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.04.010_bib104","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00216-021-03702-z","article-title":"Recent advances in the detection of interferon-gamma as a TB biomarker","volume":"414","author":"Januarie","year":"2022","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.resinv.2023.04.010_bib105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.talanta.2018.06.074","article-title":"Sensitive detection of cytokine in complex biological samples by using MB track mediated DNA walker and nicking enzyme assisted signal amplification method combined biosensor","volume":"189","author":"Zhang","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.resinv.2023.04.010_bib106","article-title":"Identification of serum microRNA biomarkers\u00a0for\u00a0tuberculosis using RNA-seq","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2023.04.010_bib107","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fmicb.2014.00549","article-title":"Pathogen- derived biomarkers for active tuberculosis diagnosis","volume":"5","author":"Tucci","year":"2014","journal-title":"Front Microbiol"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534523000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534523000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:33:47Z","timestamp":1761950027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534523000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":107,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2212534523000503"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2023.04.010","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status and future landscape of diagnosing tuberculosis infection","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2023.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}]}}